You are using an UNSUPPORTED version of browser, please try to update your browser.

Title: Mifepristone Abortion Medication
Procurement
Health and Mental Hygiene (DOHMH)
DIXON-SHANE LLC R & S NORTHEAST LLC
0049 Sandmeyer Ln , Philadelphia, PA, 19116-3501
Goods
Sole Source
11/21/2023
Award
$2,448,000.00

PIN#81623S0007001

DOHMH has determined that there is no future competition can be developed since Dixon-Shane LLC is the exclusive distributor of the Mifepristone (abortion) medication that is the only product listed for marketing.
Description

DOHMH will purchase Mifepristone tablets, 200mg, directly from Dixon-Shane LLC R&S Northeast LLC. In order to mitigate the threat to public health posed by the recent supreme court decision, DOHMH Bureau of Public Health Clinics (BPHC) plans to expand its reproductive services within the sexual health clinics to include medication abortions by adding all necessary protocols, procedures, supplies and medications beginning January 1, 2023. The Duration of this contract is for six (6) years with no options to renew. 


Disclaimer: Pursuant to Section 103 (2) of the New York State General Municipal Law, New York City Charter Section 1066 and the City of New York Procurement Policy Board Rules, The City Record is the official paper of the City of New York. It is published each weekday except legal holidays. The print edition of The City Record is the official publication for the following notices: public hearings, meetings, court notices, property dispositions, procurements (solicitations and awards), agency public hearings, agency rules, and special materials which include changes in personnel. This electronic version of The City Record is offered solely for the convenience of readers.